Total Payments
$148,341
2024 Payments
$26,681
Companies
10
Transactions
118
Medicare Patients
153
Medicare Billing
$22,038
Payment Breakdown by Category
Other$104,500 (70.4%)
Travel$20,619 (13.9%)
Consulting$19,900 (13.4%)
Food & Beverage$3,315 (2.2%)
Education$6.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $104,500 | 30 | 70.4% |
| Travel and Lodging | $20,619 | 39 | 13.9% |
| Consulting Fee | $19,900 | 3 | 13.4% |
| Food and Beverage | $3,315 | 45 | 2.2% |
| Education | $6.81 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $108,300 | 58 | $0 (2024) |
| TESARO, Inc. | $29,213 | 28 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $8,219 | 8 | $0 (2018) |
| Intuitive Surgical, Inc. | $2,125 | 18 | $0 (2019) |
| ABBVIE INC. | $125.57 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $105.01 | 1 | $0 (2022) |
| Clovis Oncology, Inc. | $96.51 | 1 | $0 (2018) |
| Mallinckrodt LLC | $92.02 | 1 | $0 (2017) |
| Ethicon US, LLC | $40.11 | 1 | $0 (2023) |
| Eisai Inc. | $23.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,681 | 19 | GlaxoSmithKline, LLC. ($26,555) |
| 2023 | $17,701 | 13 | GlaxoSmithKline, LLC. ($17,637) |
| 2022 | $40,829 | 21 | GlaxoSmithKline, LLC. ($40,724) |
| 2021 | $21,784 | 8 | GlaxoSmithKline, LLC. ($21,784) |
| 2020 | $1,600 | 1 | GlaxoSmithKline, LLC. ($1,600) |
| 2019 | $2,125 | 18 | Intuitive Surgical, Inc. ($2,125) |
| 2018 | $8,347 | 10 | Ipsen Biopharmaceuticals, Inc ($8,219) |
| 2017 | $29,274 | 28 | TESARO, Inc. ($29,182) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $706.41 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $199.00 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $765.60 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | Cash or cash equivalent | $44.22 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $3,573.02 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $202.27 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $116.65 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $152.11 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $99.93 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $55.00 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $120.18 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.57 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $40.11 | General |
| Category: Wound Closure | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $876.45 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $124.27 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 30 | 96 | $22,908 | $6,190 |
| 2022 | 3 | 60 | 152 | $33,692 | $9,775 |
| 2021 | 2 | 30 | 45 | $12,100 | $3,256 |
| 2020 | 2 | 33 | 58 | $10,599 | $2,817 |
Total Patients
153
Total Services
351
Medicare Billing
$22,038
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 59 | $15,989 | $4,407 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 37 | $6,919 | $1,783 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 65 | $17,615 | $5,093 | 28.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 48 | $8,784 | $2,705 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 25 | 39 | $7,293 | $1,978 | 27.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $5,742 | $1,681 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 19 | 34 | $6,358 | $1,575 | 24.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 25 | $5,009 | $1,537 | 30.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 33 | $5,590 | $1,281 | 22.9% |
About Dr. Matthew Anderson, MD
Dr. Matthew Anderson, MD is a Gynecologic Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952482994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Anderson, MD has received a total of $148,341 in payments from pharmaceutical and medical device companies, with $26,681 received in 2024. These payments were reported across 118 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($104,500).
As a Medicare-enrolled provider, Anderson has provided services to 153 Medicare beneficiaries, totaling 351 services with total Medicare billing of $22,038. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Obstetrics & Gynecology
- Location Tampa, FL
- Active Since 10/18/2006
- Last Updated 11/01/2018
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1952482994
Products in Payments
- ZEJULA (Drug) $116,350
- JEMPERLI (Biological) $21,141
- Onivyde (Drug) $8,219
- Da Vinci Surgical System (Device) $2,125
- ELAHERE (Drug) $125.57
- ENHERTU (Drug) $105.01
- Rubraca (Drug) $96.51
- OFIRMEV (Drug) $92.02
- STRATAFIX (Device) $40.11
- Lenvima (Drug) $23.73
- VARUBI (Drug) $22.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Tampa
Robert Wenham, Md, MD
Gynecologic Oncology — Payments: $252,784
Gynecologic Oncology $252,784
Dr. Erin George, M.d, M.D
Gynecologic Oncology — Payments: $54,068
Gynecologic Oncology $54,068
Jing-Yi Chern, Md, MD
Gynecologic Oncology — Payments: $42,967
Gynecologic Oncology $42,967
Dr. Hye Sook Chon, M.d, M.D
Gynecologic Oncology — Payments: $25,874
Gynecologic Oncology $25,874
Dr. Mitchel Hoffman, M.d, M.D
Gynecologic Oncology — Payments: $6,290
Gynecologic Oncology $6,290
Mrs. Monica Avila, M.d, M.D
Gynecologic Oncology — Payments: $5,462
Gynecologic Oncology $5,462